FIELD: pharmacology.
SUBSTANCE: invention relates to a potassium salt of 5-hydroxynicotinic acid of the formula C6H4NO5K, , which has cardioprotective activity.
EFFECT: increased compound activity.
2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
3-(1H-BENZIMIDAZOL-2-YL) -1,2,2-TRIMETHYL CYCLOPENTANCARBONIC ACID WITH CARDIOPROTECTIVE ACTIVITY | 2017 |
|
RU2645356C1 |
METHOD OF CARDIOPROTECTIVE ACTIVITY ESTIMATION OF PHARMACOLOGICAL FACILITIES | 2017 |
|
RU2643104C1 |
AGENT HAVING CARDIOTONIC ACTIVITY | 2012 |
|
RU2521213C1 |
PLANT-DERIVED AGENT WITH CARDIOTONIC ACTIVITY IN CHRONIC HEART FAILURE | 2017 |
|
RU2654706C1 |
AGENT POSSESSING CARDIOPROTECTIVE, ANTIPLATELET, ANTICOAGULANT AND MEMBRANE-PROTECTIVE PROPERTIES UNDER STRESS STIMULATION | 2013 |
|
RU2531080C1 |
AGENT POSSESSIVE CARDIOPROTECTIVE ACTION UNDER STRESS STIMULATION | 2013 |
|
RU2531082C1 |
METHOD OF CORRECTION OF TISSUE METABOLISM AT HYPOXIA | 1995 |
|
RU2123850C1 |
ASN-BOKERIYA-BOLDYREV CARDIOPLEGIC SOLUTION | 2009 |
|
RU2413502C1 |
GAMMA-HYDROXYPROPYLAMMONIUM-5-HYDROXYNICOTINATE ELICITING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND HYPOLIPIDEMIC ACTIVITY | 2003 |
|
RU2245329C1 |
CRYSTALLOID CARDIOPLEGIC SOLUTION | 2009 |
|
RU2423135C2 |
Authors
Dates
2018-01-10—Published
2017-03-06—Filed